EMEA-003475-PIP01-23

Opinion/decision on a Paediatric investigation plan (PIP): Uplizna, Inebilizumab, decision type: P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s), therapeutic area: Nervous system disorders, PIP number: P/0471/2023

EMEA-003498-PIP01-23

Veterinary medicines European public assessment report (EPAR): Equilis Prequenza, vaccine against equine influenza in horses, Status: Authorised

EMEA-003466-PIP01-23

Veterinary medicines European public assessment report (EPAR): Equilis Te, Adjuvanted vaccine against tetanus, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Equilis Prequenza Te, vaccine against equine influenza and tetanus in horses, Status: Authorised

Minutes of the CHMP meeting 11-14 November 2024

Clinical Trials Information System (CTIS) bitesize talk: Change of sponsor in CTIS, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 5 March 2025, 15:30 (CET) to 5 March 2025, 17:00 (CET)

List of withdrawn medicinal products in accordance with Art. 123(4) of the Directive (1 January - 31 December 2024)